Skip to main content
The BMJ logoLink to The BMJ
. 1994 Apr 2;308(6933):867–868. doi: 10.1136/bmj.308.6933.867

Vitamin K for neonates: the controversy.

G Draper, A McNinch
PMCID: PMC2539849  PMID: 8173359

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amédée-Manesme O., Lambert W. E., Alagille D., De Leenheer A. P. Pharmacokinetics and safety of a new solution of vitamin K1(20) in children with cholestasis. J Pediatr Gastroenterol Nutr. 1992 Feb;14(2):160–165. doi: 10.1097/00005176-199202000-00007. [DOI] [PubMed] [Google Scholar]
  2. Choonara I. A., Park B. K. Plasma concentrations after oral or intramuscular vitamin K1 in neonates. Arch Dis Child. 1985 Dec;60(12):1203–1204. doi: 10.1136/adc.60.12.1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Croucher C., Azzopardi D. Compliance with recommendations for giving vitamin K to newborn infants. BMJ. 1994 Apr 2;308(6933):894–895. doi: 10.1136/bmj.308.6933.894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ekelund H., Finnström O., Gunnarskog J., Källén B., Larsson Y. Administration of vitamin K to newborn infants and childhood cancer. BMJ. 1993 Jul 10;307(6896):89–91. doi: 10.1136/bmj.307.6896.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ekelund H. Late haemorrhagic disease in Sweden 1987-89. Acta Paediatr Scand. 1991 Oct;80(10):966–968. doi: 10.1111/j.1651-2227.1991.tb11763.x. [DOI] [PubMed] [Google Scholar]
  6. Golding J., Greenwood R., Birmingham K., Mott M. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ. 1992 Aug 8;305(6849):341–346. doi: 10.1136/bmj.305.6849.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Golding J., Paterson M., Kinlen L. J. Factors associated with childhood cancer in a national cohort study. Br J Cancer. 1990 Aug;62(2):304–308. doi: 10.1038/bjc.1990.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Klebanoff M. A., Read J. S., Mills J. L., Shiono P. H. The risk of childhood cancer after neonatal exposure to vitamin K. N Engl J Med. 1993 Sep 23;329(13):905–908. doi: 10.1056/NEJM199309233291301. [DOI] [PubMed] [Google Scholar]
  9. Logan S., Stanton A. Screening for biliary atresia. Lancet. 1993 Jul 31;342(8866):256–256. doi: 10.1016/0140-6736(93)91814-3. [DOI] [PubMed] [Google Scholar]
  10. MEYER T. C., ANGUS J. The effect of large doses of synkavit in the newborn. Arch Dis Child. 1956 Jun;31(157):212–215. doi: 10.1136/adc.31.157.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McNinch A. W., Tripp J. H. Haemorrhagic disease of the newborn in the British Isles: two year prospective study. BMJ. 1991 Nov 2;303(6810):1105–1109. doi: 10.1136/bmj.303.6810.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Olsen J. H., Hertz H., Blinkenberg K., Verder H. Vitamin K regimens and incidence of childhood cancer in Denmark. BMJ. 1994 Apr 2;308(6933):895–896. doi: 10.1136/bmj.308.6933.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rennie J. M., Kelsall A. W. Vitamin K prophylaxis in the newborn--again. Arch Dis Child. 1994 Mar;70(3):248–251. doi: 10.1136/adc.70.3.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Whitfield M. F., Salfield S. A. Accidental administration of Syntometrine in adult dosage to the newborn. Arch Dis Child. 1980 Jan;55(1):68–70. doi: 10.1136/adc.55.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. von Kries R., Göbel U. Oral vitamin K prophylaxis and late haemorrhagic disease of the newborn. Lancet. 1994 Feb 5;343(8893):352–352. doi: 10.1016/s0140-6736(94)91187-8. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES